# Blackford Analysis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/blackford-analysis

- Industry: Healthcare IT
- Headquarters: Edinburgh, UK
- Website: www.blackfordanalysis.com
- Total disclosed funding: $1.3M
- Latest round: Seed (Sep 14, 2012)
- Investors on record: 2

## About

Blackford Analysis Ltd is a healthcare technology company specializing in AI solutions to optimize medical imaging workflows, enhancing diagnostic accuracy and patient outcomes through seamless integration of multiple AI applications.Founded in 2010, Blackford Analysis Ltd operates from Edinburgh, UK, providing AI solutions that integrate into medical imaging workflows. The company has undergone strategic pivots, focusing on enhancing its product offerings and expanding its global reach. The founder, Ben Panter, has a background in healthcare technology and has led the company through several funding rounds, with the most recent investment round occurring in January 2023, where they raised USD 0.690 mn, bringing the total amount raised to USD 0.690 mn.Blackford Analysis specializes in advanced AI solutions for the healthcare sector, particularly in medical imaging. Their core product, the Blackford Platform, connects various AI applications, ensuring efficient tool management and continuous performance monitoring. The platform optimizes diagnostic confidence and automates clinical workflows, serving a diverse clientele including hospitals and healthcare institutions across North America, Europe, and parts of Asia.In the most recent fiscal year, 2024, Blackford Analysis reported a revenue of USD 1,355,288.30, alongside an EBITDA of -USD 18,884,131.10. Revenue is generated through subscription models for the Blackford Platform, which provides access to over 140 contracted AI applications across multiple clinical specialties, with a strong emphasis on B2B transactions.In January 2023, Bayer AG agreed to acquire Blackford Analysis Ltd for an undisclosed amount, with the transaction expected to close in late 2023. This acquisition aims to foster innovation in radiology, particularly in developing and integrating AI within clinical workflows. The strategic partnership is anticipated to enhance product offerings and facilitate entry into new markets, leveraging Bayer's resources to expand Blackford's AI solutions in radiology beyond current geographical constraints.

## Funding rounds

- Seed, Sep 14, 2012, $1.3M — Archangels Investors Limited, Scottish Enterprise

## Investors

- Archangels Investors Limited — Seed
- Scottish Enterprise (https://capitalatlas.ai/funds/scottish-enterprise) — Seed